Innovation for Antibiotics Development and Preservation
Antimicrobial Resistance (AMR) is a growing global health threat. WHO is currently developing a Global Action Plan for AMR (GAP-AMR) that will be discussed by the 68th World Health Assembly in May 2015. The plan aims to provide guidance on the development of a multi-sectoral comprehensive, coordinated and sustained approach to address AMR. One goal of the GAP-AMR is to establish a mechanism to promote the discovery and development of novel antibiotics that are safe, and effective and ensure that any new molecules are accessible, and rationally used to avoid the development of resistance. Market failures in the discovery and development of new antibiotics are well documented which underscore the need for innovate approaches and models to sustainably encourage research and development (R&D) in this area.